Article
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.
The Journal of clinical investigation - 1 Sept 2008
Howe Steven J, Mansour Marc R, Schwarzwaelder Kerstin, Bartholomae Cynthia, Hubank Michael, Kempski Helena, Brugman Martijn H, Pike-Overzet Karin, Chatters Stephen J, de Ridder Dick, Gilmour Kimberly C, Adams Stuart, Thornhill Susannah I, Parsley Kathryn L, Staal Frank J T, Gale Rosemary E, Linch David C, Bayford Jinhua, Brown Lucie, Quaye Michelle, Kinnon Christine, Ancliff Philip, Webb David K, Schmidt Manfred, von Kalle Christof, Gaspar H Bobby, Thrasher Adrian J
Abstract excerpt
X-linked SCID (SCID-X1) is amenable to correction by gene therapy using conventional gammaretroviral vectors. Here, we describe the occurrence of clonal T cell acute lymphoblastic leukemia (T-ALL) promoted by insertional mutagenesis in a completed gene therapy trial of 10 SCID-X1 patients. Integr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
